DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Roden M, Weng J, Eilbracht J. et al.
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Diabetes Endocrinol 2013;
1: 208-219
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.